Jeong-Hoon Jang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeong-Hoon Jang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Amir Hossein Mohseni
Department of Microbiology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran
13 shared publications - Andrea Cercek
Memorial Sloan Kettering Cancer Center
13 shared publications - Barbara Miño Galvez
MD Anderson Cancer Center, Houston, TX
13 shared publications - Daniel E. Carvajal-Hausdorf
Clínica Alemana 9 , Facultad de Medicina, Universidad del Desarrollo, Santiago, Chile
13 shared publications - Dhwani N. Rupani
MD Anderson Cancer Center, Houston, TX
13 shared publications - Edith Araceli Fernández-Figueroa
Núcleo B de Innovación en Medicina de Precisión, Instituto Nacional de Medicina Genómica, Ciudad de México 14610, Mexico
13 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S1 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 1. Evaluation of sensitivity and mis-assignment rate for in silico human datasets.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S1 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 1. Evaluation of sensitivity and mis-assignment rate for in silico human datasets.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S10 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 10. Microbial regulation of IRGs drives immunotherapy sensitivity.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S10 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 10. Microbial regulation of IRGs drives immunotherapy sensitivity.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S2 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 2. Methodological concordance between independent microbial detection approaches.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S2 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 2. Methodological concordance between independent microbial detection approaches.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S3 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 3. ITMB is also strongly linked to immune pathways in TCGA gastric cancer (STAD).
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S3 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 3. ITMB is also strongly linked to immune pathways in TCGA gastric cancer (STAD).
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S4 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 4. Expression of immune checkpoint genes based on ITMB.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S4 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 4. Expression of immune checkpoint genes based on ITMB.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S5 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 5. Comparison of bacterial composition differences between MMRp and MMRd CRC tumors.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S5 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 5. Comparison of bacterial composition differences between MMRp and MMRd CRC tumors.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S6 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 6. Validation of in vitro microbial detection via DNA vs RNAseq.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S6 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 6. Validation of in vitro microbial detection via DNA vs RNAseq.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S7 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 7. Identifying ITMB+ and ITMB- cells in single cell sequencing.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S7 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 7. Identifying ITMB+ and ITMB- cells in single cell sequencing.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S8 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 8. Impact of sustained vs. early-terminated local tumor microbial depletion on ICB response.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S8 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 8. Impact of sustained vs. early-terminated local tumor microbial depletion on ICB response.
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Fig S9 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 9. Tumor Microbiome composition upon local antibiotics treatment.
- 2 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig S9 from Tumor Microbial Burden Drives Immune Responses through Regulation of Interferon Signaling
Supplementary Figure 9. Tumor Microbiome composition upon local antibiotics treatment.